Finerenone 20mg Tablets are a prescription cardiovascular and renal medicine containing finerenone 20mg as the active ingredient. They are the generic equivalent of Kerendia® 20mg, the reference brand product developed by Bayer. Finerenone is a non-steroidal mineralocorticoid receptor antagonist (MRA) — a newer class of aldosterone blocker distinct from steroidal MRAs such as spironolactone and eplerenone. Generic Kerendia® 20mg is used in the treatment of chronic kidney disease (CKD) associated with type 2 diabetes mellitus (T2DM) in eligible adult patients. Finerenone 20mg tablets are available internationally across the USA, UK, Australia, UAE, Germany, France, Russia, South Korea and other countries worldwide.
| Detail | Information |
|---|---|
| Generic Name | Finerenone |
| Brand Reference | Kerendia® 20mg |
| Strength | 20mg |
| Dosage Form | Film-Coated Tablet |
| Drug Class | Non-Steroidal Mineralocorticoid Receptor Antagonist (MRA) |
| ATC Code | C03DA05 |
| Active Ingredient | Finerenone 20mg per tablet |
| Route | Oral |
| Prescription Required | Yes — prescription-only in all major markets |
| Generic Status | Generic equivalent of Kerendia® 20mg |
| Pack Size | Varies by manufacturer and market |
| Manufacturer | Multiple generic manufacturers |
| Availability | USA · UK · Australia · UAE · Germany · France · Russia · South Korea · Worldwide |
Finerenone 20mg tablets are indicated for the treatment of chronic kidney disease (CKD) associated with type 2 diabetes mellitus in adult patients. Approved indications vary by country and regulatory authority.
United States: Kerendia® (finerenone) is FDA-approved for reducing the risk of sustained eGFR decline, end-stage kidney disease, cardiovascular death, non-fatal myocardial infarction and hospitalisation for heart failure in adults with CKD associated with type 2 diabetes. The 20mg dose is the target maintenance dose following titration from 10mg.
United Kingdom / EU: Finerenone (Kerendia®) is EMA-approved for the treatment of chronic kidney disease (stages 3 and 4 with albuminuria) associated with type 2 diabetes in adults. The maintenance dose of finerenone 20mg is reached after initial assessment of serum potassium and renal function on the 10mg starting dose.
Australia: Finerenone 20mg Australia — Kerendia® and generic finerenone products are subject to TGA registration. Confirm current ARTG listing and PBS subsidisation status with your prescriber or pharmacist.
UAE / Gulf: Finerenone products are subject to UAE Ministry of Health registration. Availability of finerenone 20mg UAE depends on the specific registered product. Consult a UAE-licensed physician or pharmacist for current availability.
Germany: Finerenon 20mg is available in Germany as Kerendia® and, where applicable, as generic finerenone products. All are prescription-only (rezeptpflichtig).
France: Finérénone 20mg is available in France as Kerendia® and subject to HAS reimbursement decisions. Consult your pharmacist for current reimbursement and availability status.
Russia: Финеренон 20 мг is available in Russia as Кередиа® 20 мг and subject to Russian Ministry of Health registration. Consult Russian prescribing information for current indications.
South Korea: 피네레논 20mg is registered for prescription use in South Korea per MFDS-approved product information. Consult your physician or pharmacist for current availability.
Always follow the prescribing information applicable to your country and the guidance of your licensed healthcare professional.
Finerenone is a selective, non-steroidal mineralocorticoid receptor antagonist (ns-MRA). It works by binding to and blocking the mineralocorticoid receptor (MR) — the same receptor targeted by aldosterone and by steroidal MRAs such as spironolactone and eplerenone.
What makes finerenone different from steroidal MRAs:
By blocking aldosterone-driven mineralocorticoid receptor activation in the kidneys, heart and blood vessels, finerenone reduces inflammation and fibrosis in both organs — key mechanisms in CKD progression and cardiovascular risk in patients with type 2 diabetes.
Both strengths contain finerenone as the active ingredient. The difference is the dose:
Dose escalation from 10mg to 20mg is guided by:
Do not adjust your finerenone dose without guidance from your prescriber.
| Feature | Finerenone 20mg | Eplerenone 50mg | Spironolactone 25mg |
|---|---|---|---|
| Class | Non-steroidal MRA | Steroidal MRA | Steroidal MRA |
| MR Selectivity | High | High | Low |
| Primary Indication | CKD + T2DM | Heart failure / Hypertension | Heart failure / Hypertension / Other |
| Hormone-related side effects | Lower risk | Lower than spironolactone | Higher risk |
| Hyperkalaemia risk | Yes — monitor | Yes — monitor | Yes — monitor |
| ATC Code | C03DA05 | C03DA04 | C03DA01 |
These medicines are not interchangeable. Do not substitute one for another without specific medical guidance.
Kerendia® 20mg is the originator brand containing finerenone 20mg developed by Bayer. Generic finerenone 20mg tablets contain the same active ingredient at the same strength but may differ in:
Generic products are not automatically interchangeable with Kerendia® in every market — local substitution rules apply. Consult your pharmacist before switching between branded and generic finerenone products.
Hyperkalaemia (High Potassium) — Most Important Risk
The most significant safety concern with finerenone 20mg is hyperkalaemia (elevated serum potassium). This risk is present at both the 10mg and 20mg doses and is higher in patients with:
Serum potassium must be measured before initiating finerenone, before escalating to 20mg, and periodically during treatment.
Contraindications
Finerenone 20mg must not be used in patients with:
Drug Interactions
Finerenone is primarily metabolised by CYP3A4. Significant interactions include:
Renal Monitoring
eGFR should be monitored before initiation and periodically during treatment. Dose adjustment or interruption may be required if eGFR declines significantly.
Always read the patient information leaflet (PIL) and prescribing information applicable to your country before taking finerenone.
| Country | Status | Notes |
|---|---|---|
| USA | Prescription-only (FDA-approved) | Kerendia® 20mg; generic finerenone 20mg |
| UK | Prescription-only (MHRA/EMA) | Kerendia® 20mg; NICE guidance applies |
| Australia | Prescription-only (TGA) | ARTG registration; PBS status — confirm with pharmacist |
| UAE / Dubai | Prescription-only | Subject to MOH product registration |
| Germany | Prescription-only | Kerendia® 20mg; generic products where available |
| France | Prescription-only | Kerendia® 20mg; HAS reimbursement applies |
| Russia | Prescription-only | Кередиа® 20 мг; Russian MOH registration |
| South Korea | Prescription-only | Per MFDS-approved labeling |
| Worldwide | Varies by country | Contact us for availability in your market |
What is Finerenone 20mg used for?
Finerenone 20mg is used to treat chronic kidney disease (CKD) associated with type 2 diabetes in adults. It reduces the risk of kidney disease progression, cardiovascular death, heart attack and hospitalisation for heart failure in eligible patients. It is the target maintenance dose, reached after titration from finerenone 10mg.
Is Finerenone 20mg the generic for Kerendia® 20mg?
Yes. Kerendia® 20mg is the originator brand containing finerenone 20mg. Generic finerenone 20mg tablets contain the same active ingredient and strength, though inactive ingredients, appearance and manufacturer may differ.
What is the difference between Finerenone 10mg and 20mg?
Finerenone 10mg is the starting dose used to assess tolerability and monitor potassium and eGFR. Finerenone 20mg is the target maintenance dose, titrated up from 10mg after 4 weeks if potassium and renal function allow. Do not change your dose without medical guidance.
Is Finerenone the same as Spironolactone or Eplerenone?
No. Finerenone is a non-steroidal mineralocorticoid receptor antagonist with a different chemical structure, selectivity profile and approved indications compared to spironolactone and eplerenone, which are steroidal MRAs. They are not interchangeable.
Does Finerenone 20mg raise potassium levels?
Yes. Finerenone can cause hyperkalaemia (elevated blood potassium). Regular serum potassium monitoring is required before starting, before dose escalation to 20mg and periodically during treatment.
Can I buy Finerenone 20mg tablets online?
Finerenone 20mg is prescription-only in the USA, UK, Australia, UAE and most markets worldwide. A valid prescription from a licensed prescriber is required.
Is Finerenone 20mg available in Australia?
Finerenone 20mg products are subject to TGA registration in Australia. Confirm current ARTG listing and PBS subsidisation with your prescriber or pharmacist.
Is Finerenone 20mg available in the UAE?
Finerenone products are subject to UAE Ministry of Health registration. Consult a UAE-licensed physician or pharmacist for current availability of finerenone 20mg in the UAE.
What is Finerenon 20mg in Germany?
Finerenon is the German-language name for finerenone. Kerendia® 20mg is the registered brand in Germany. Generic finerenone 20mg products may also be available. All are prescription-only (rezeptpflichtig).
Can Finerenone 20mg be taken with ACE inhibitors or ARBs?
Finerenone can be used with ACE inhibitors and ARBs, but the combination increases the risk of hyperkalaemia. Serum potassium must be monitored carefully. Do not start finerenone if potassium exceeds the threshold specified in the applicable prescribing information.
This information is provided for educational and commercial reference purposes only and is not a substitute for professional medical advice, diagnosis or treatment. Finerenone 20mg is a prescription-only cardiovascular and renal medicine with important potassium, renal function, CYP3A4 interaction and drug-interaction considerations. Always use it according to the applicable prescribing information and the advice of a qualified healthcare professional licensed in your country.
Last Updated: September 25, 2026
Orders ship from our India Head Office within 1–2 business days of confirmation. We include full customs documentation — HS codes, certificates of origin, and pharmaceutical export permits.
Estimated delivery: 3–7 business days to UK. 7–10 business days to UAE, Saudi Arabia and Gulf countries. 10–15 days for USA and Asian countries.
All packages arrive in plain, unmarked brown boxes. No pharmacy name or medication details on the outside.
Only logged in customers who have purchased this product may leave a review.
Reviews
There are no reviews yet.